Importantly, our finding of higher intracellular than cell surface checkpoint expression on CD3+ T cells and CD138+ MM cells in patient BMMC suggests that high intracellular levels of checkpoints may provide a continuous source of checkpoint molecules for translocation to the cell surface, thereby maintaining ongoing checkpoint-driven immune resistance in MM. Here, SDC1 is linked to Miyoshi myopathy.